Consequences of targeted treatments for second-line therapy

MLA

Samanta Cupini, et al. “Consequences of Targeted Treatments for Second-Line Therapy.” Annals of Oncology, vol. 21, Oct. 2010, pp. vii234-vii240. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5b51285f8387da2d2534e89f29a678df&authtype=sso&custid=ns315887.

APA

Samanta Cupini, Carmelo Tibaldi, C. Barbara, Lorenza Landi, E. De Maio, Gabriele Minuti, Armida D’Incecco, Federico Cappuzzo, S. Bursi, R. Di Marsico, & M. D’Arcangelo. (2010). Consequences of targeted treatments for second-line therapy. Annals of Oncology, 21, vii234-vii240.

Chicago

Samanta Cupini, Carmelo Tibaldi, C. Barbara, Lorenza Landi, E. De Maio, Gabriele Minuti, Armida D’Incecco, et al. 2010. “Consequences of Targeted Treatments for Second-Line Therapy.” Annals of Oncology 21 (October): vii234-vii240. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5b51285f8387da2d2534e89f29a678df&authtype=sso&custid=ns315887.